Improving Access to Preventive Chemotherapy for Neglected Tropical Diseases
Using Community Mapping and Participatory Research
Among Mobile and Migrant Populations in Nigeria
Led by Uwemedimo Friday Ekpo · Updated on 2026-07-16
5760
Participants Needed
1
Research Sites
17 weeks
Total Duration
AI-Summary
What This Trial Is About
Neglected tropical diseases NTDs affect over one billion people worldwide, especially in remote and underserved communities. This research evaluates strategies to improve access to preventive chemotherapy among mobile and migrant populations MMPs in Nigeria, who often miss treatment during mass drug administration MDA campaigns. The study focuses on understanding migration patterns and social networks to enhance treatment reach and coverage in these hard-to-reach groups.
The study involves a multi-site approach across 15 communities in three Nigerian states with pastoralist, fishing, and agrarian populations. It includes four phases assessing baseline NTD burden and treatment coverage, mapping migration and social networks, co-developing tailored delivery strategies with communities, and implementing and evaluating the modified mass administration of medicines MAM campaign. The new approach adapts timing, locations, and supportive livelihood services to better fit MMPs mobility and needs.
Participants will provide biological samples and participate in surveys, interviews, and workshops to inform and assess the intervention. Researchers will measure treatment reach, coverage, compliance, and acceptability, as well as implementation outcomes such as adoption, fidelity, and sustainability. The study aims to generate evidence on the feasibility and impact of the community-informed delivery model to support inclusive NTD programming in Nigeria by the end of 2027.
CONDITIONS
Brief Title
Expanding Access to Preventive Chemotherapy Among Mobile and Migrant Populations
Research Team
U
Uwem Ekpo, PhD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match. Sign up to get personalized trial recommendations delivered to your inbox.
Children aged 5 to 14 years or adult heads of households from mobile or migrant populations
Permanent or semi-permanent residents of the study communities
Have missed one or more previous rounds of treatment for onchocerciasis or lymphatic filariasis
Willing to provide biological samples and participate in interviews, surveys, and workshops
Provide informed consent or assent with parental or guardian consent for minors
You will not qualify if you...
Temporary visitors not meaningfully residing in the study communities
Not part of the targeted mobile or migrant populations
Unable or unwilling to provide biological samples or participate in study procedures
Decline informed consent or assent, or whose parent or guardian declines consent
Severely ill or have medical conditions that make participation unsafe or inappropriate
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Baseline Assessment and Mapping
Duration - Up to 4 months
Participants provide biological samples and take part in surveys and workshops to assess disease burden, migration patterns, and social networks.
Multiple visits for surveys and sample collection
Strategy Development
Duration - Up to 1 month
Participants and communities collaborate using participatory research to develop tailored strategies for delivering preventive chemotherapy to mobile and migrant populations.
Participatory workshops
Implementation and Evaluation
Duration - Approximately 1 month
The modified mass administration of medicines strategy is implemented and evaluated for reach, coverage, compliance, and acceptability among participants.
Visits during and after medicine distribution
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
HEALTH_SERVICES_RESEARCH
Number of Arms
1
Similar Trials
Evaluating Active Infection in Travelers and Migrants with Chronic Schistosomiasis Using Diagnostic Tests
Comparing Moxidectin Versus Ivermectin with Diethylcarbamazine and Albendazole for Treating Lymphatic Filariasis, Scabies, and Strongyloidiasis in Fiji
Improving Access to Preventive Chemotherapy for Neglected Tropical Diseases
Using Community Mapping and Participatory Research
Among Mobile and Migrant Populations in Nigeria
Pilot Study of Arpraziquantel Treatment for Schistosomiasis in Preschool Children
Using Routine Health Campaigns in Kenya, Cte dIvoire, and Uganda
Assessing the Spread of Multiple Infectious Diseases in Cambodia Using a One Health Approach
Including Children and Adults Ages 2 to 75 Years
A Nationwide Study to Guide Public Health Actions
Have more questions? Get in touch with our team for quick support
Published Research Related To This Trial
Sensitivity of Three Impact Assessment Methodologies in Adjusting Preventive Chemotherapy Treatment Decisions for Schistosomiasis Elimination in Ondo State, Nigeria.
Uwem F Ekpo, Francisca O Olamiju, Hammed O Mogaji...
A Post-Lockdown Assessment of Albendazole Treatment Coverage in Mass Drug Administration Campaigns Implemented Before and During COVID-19 Pandemic in Ekiti, Southwest Nigeria.
Hammed O Mogaji, Hilary I Okoh, Abiodun M Lawal...
Prevalence, intensity and risk factors of soil-transmitted helminthiasis after five effective rounds of preventive chemotherapy across three implementation units in Ondo State, Nigeria.
Hammed O Mogaji, Francisca O Olamiju, Fajana Oyinlola...
Co-production of informal settlement health: a community based participatory research program for building healthy communities in urban informal settlements of Salvador, Brazil.
Hammed Mogaji, Lopez Yeimi Alexandra Alzate, Lívia Almeida Figuerêdo...
Understanding the barriers and facilitators related to never treatment during mass drug administration among mobile and migrant populations in Mali: a qualitative exploratory study.
Moussa Sangare, Abdoul Fatao Diabate, Yaya Ibrahim Coulibaly...